Ventilator-associated Bacterial Pneumonia

Infectious Disease

6 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Approved(3)

Drug	Company
XACDURO	Innoviva, Inc. (INVA)
XACDURO®	Innoviva, Inc. (INVA)
zerbaxa	Curative Biotechnology Inc (CUBT)

Phase 3(2)

Drug	Company
ceftazidime-avibactam	NYMOX PHARMACEUTICAL CORP (NYMXF)
meropenem	NYMOX PHARMACEUTICAL CORP (NYMXF)

Preclinical(1)

Drug	Company
vibativ	SCICLONE PHARMACEUTICALS INC (SCLN)

BioSniper tracks 6 drugs in development for Ventilator-associated Bacterial Pneumonia across 4 companies.

There are 1 clinical trial targeting Ventilator-associated Bacterial Pneumonia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.